MEBUCAÏNE Dolo cpr sucer 8.75 mg 16 pce

7680678800039 CH-67880 R02AX01 12.03.2.
MEBUCAÏNE Dolo cpr sucer 8.75 mg 16 pce
MEBUCAÏNE Dolo cpr sucer 8.75 mg 16 pce
MEBUCAÏNE Dolo cpr sucer 8.75 mg 16 pce
1 / 3
google

Details

Product number
6788001
CPT
-
Packaging group
16
Unit
Tablette(n)
Composition
flurbiprofenum 8.75 mg, isomaltum 2034 mg, maltitolum 427.5 mg, E 124 0.01 mg, E 110 0.08 mg, acesulfamum kalicum, macrogolum 300, aromatica (Orange) cum citralum et limonenum et citronellolum, kalii hydroxidum, levomentholum, pro compresso.

Articles (1)

Mebucaïne Dolo, Lutschtablette
Lutschtablette
16
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/01/2025
Patient information leaflet
Français
22/01/2025
Patient information leaflet
Italien
22/01/2025
Professional SmPC
Allemand
22/01/2025
Professional SmPC
Français
22/01/2025
Professional SmPC
Italien
22/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
8.75 MG Substance Wirkstoff (Principe actif)
(N/A)
2039.4 MG Substance HBESI
(N/A)
427.5 MG Substance HBESI
(N/A)
0.01 MG Substance HBESI
(N/A)
0.08 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
67880
Drug name
Mebucaïne Dolo, Lutschtablette
Galenic form
LUTT
ATC Code
R02AX01
Authorization status
Z
Dispensation category
D
First authorization
09/09/2021
Authorization expiration date
08/09/2026
IT number
12.03.2.
Domain
Human medicine
Field of application
kurzzeitige symptomatische Behandlung schmerzhafter Entzündungen der Rachenschleimhaut

Packaging details

Description (FR)
MEBUCAÏNE Dolo cpr sucer 8.75 mg 16 pce
Description (DE)
MEBUCAÏNE Dolo Lutschtabl 8.75 mg 16 Stk
Market launch
09/09/2021
Narcotic (BTM)
No

Other packaging sizes